SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-099177
Filing Date
2008-05-01
Accepted
2008-05-01 16:15:59
Documents
3
Period of Report
2008-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16376
2 OFFER LETTER dex101.htm EX-10.1 22076
3 GRAPHIC g49253img001.jpg GRAPHIC 3209
  Complete submission text file 0001193125-08-099177.txt   44724
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-55166 | Film No.: 08794943
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1